| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-05 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.0002 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.23 |
0.0004 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.15 |
0.002 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |